Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.

Home » Publications » Rigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
TitleRigorous Randomized Controlled Trial Implementation in the Era of COVID-19.
Publication TypeJournal Article
Year of Publication2020
AuthorsOldenburg CE, Doan T
JournalAm J Trop Med Hyg
Volume102
Issue6
Pagination1154-1155
Date Published2020 06
ISSN1476-1645
KeywordsAntiviral Agents, Azithromycin, Betacoronavirus, Clinical Laboratory Techniques, Coronavirus Infections, COVID-19, COVID-19 Testing, Drug Repositioning, Humans, Hydroxychloroquine, Lopinavir, Pandemics, Pneumonia, Viral, Practice Guidelines as Topic, Randomized Controlled Trials as Topic, Ritonavir, Sample Size, SARS-CoV-2, United States
DOI10.4269/ajtmh.20-0262
Alternate JournalAm J Trop Med Hyg
PubMed ID32297590
PubMed Central IDPMC7253099